What is Bicara Therapeutics's granted (in shares)?

Bicara Therapeutics (BCAX) reported granted (in shares) of 2.4M in Q1 2026.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

Bicara Therapeutics BCAX Granted (in shares)

Granted (in shares) at other companies

CHE

ChemedCHE

$110.38K+38.8%

WingstopWING

0—

Oruka Therapeutics, Inc.ORKA

1.5M-12.6%

The Hanover Insurance GroupTHG

148.1K+5.5%

LivaNovaLIVN

957.7K+31.3%

Option Care Health, Inc.OPCH

0—

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's granted (in shares)?: Bicara Therapeutics (BCAX) reported granted (in shares) of 2.4M in Q1 2026.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.